300255 常山药业
已收盘 06-12 15:00:00
资讯
新帖
简况
6月11日常山药业跌6.88%,创业板医药ETF国泰基金重仓该股
证券之星 · 06-11 16:32
6月11日常山药业跌6.88%,创业板医药ETF国泰基金重仓该股
6月9日常山药业涨7.65%,创业板医药ETF国泰基金重仓该股
证券之星 · 06-09
6月9日常山药业涨7.65%,创业板医药ETF国泰基金重仓该股
6月5日常山药业跌5.49%,创业板医药ETF国泰基金重仓该股
证券之星 · 06-05
6月5日常山药业跌5.49%,创业板医药ETF国泰基金重仓该股
常山药业(300255)5月29日股东户数4.69万户,较上期减少0.65%
证券之星 · 06-04
常山药业(300255)5月29日股东户数4.69万户,较上期减少0.65%
常山药业:2025年存货计提资产减值损失是由于当年末存货成本高于可变现净值
证券之星 · 06-04
常山药业:2025年存货计提资产减值损失是由于当年末存货成本高于可变现净值
常山药业:股东协议转让事项的当事人是股东,而不是公司
证券之星 · 06-04
常山药业:股东协议转让事项的当事人是股东,而不是公司
5月29日常山药业涨5.88%,创业板医药ETF国泰基金重仓该股
证券之星 · 05-29
5月29日常山药业涨5.88%,创业板医药ETF国泰基金重仓该股
股市必读:常山药业(300255)5月22日董秘有最新回复
证券之星 · 05-25
股市必读:常山药业(300255)5月22日董秘有最新回复
常山药业:截至2026年5月20日,公司的股东户数为47219户
证券之星 · 05-22
常山药业:截至2026年5月20日,公司的股东户数为47219户
常山药业:推进艾本那肽上市审评工作是公司的重点工作
证券之星 · 05-22
常山药业:推进艾本那肽上市审评工作是公司的重点工作
常山药业(300255)披露2025年度股东会决议公告,5月20日股价下跌1.44%
证券之星 · 05-20
常山药业(300255)披露2025年度股东会决议公告,5月20日股价下跌1.44%
股市必读:常山药业(300255)股东户数4.77万户,较上期减少2.45%
证券之星 · 05-18
股市必读:常山药业(300255)股东户数4.77万户,较上期减少2.45%
常山药业:截至2026年5月8日,公司的股东户数为47692户
证券之星 · 05-15
常山药业:截至2026年5月8日,公司的股东户数为47692户
5月14日常山药业跌6.84%,创业板医药ETF国泰基金重仓该股
证券之星 · 05-14
5月14日常山药业跌6.84%,创业板医药ETF国泰基金重仓该股
常山药业因业绩预测结果不准确或不及时被深圳证券交易所采取监管措施
证券之星 · 05-12
常山药业因业绩预测结果不准确或不及时被深圳证券交易所采取监管措施
常山药业:截至2026年4月30日,公司的股东户数为48892户
证券之星 · 05-08
常山药业:截至2026年4月30日,公司的股东户数为48892户
常山药业:公司未开展艾本那肽与其他同类药品的头对头临床试验
证券之星 · 05-08
常山药业:公司未开展艾本那肽与其他同类药品的头对头临床试验
常山药业(300255.SZ):达肝素钠注射液获得白俄罗斯药品注册证书
智通财经 · 05-06
常山药业(300255.SZ):达肝素钠注射液获得白俄罗斯药品注册证书
每周股票复盘:常山药业(300255)2025年亏损3.58亿元
证券之星 · 05-03
每周股票复盘:常山药业(300255)2025年亏损3.58亿元
常山药业(300255)2026年一季报简析:净利润同比增长55.21%,短期债务压力上升
证券之星 · 04-30
常山药业(300255)2026年一季报简析:净利润同比增长55.21%,短期债务压力上升
加载更多
公司概况
公司名称:
河北常山生化药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-08-19
主营业务:
河北常山生化药业股份有限公司的主营业务是肝素系列产品的研发、生产和销售。公司的主要产品是普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司近几年分别被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等,建立了国家级博士后科研工作站,有效推动公司高级人才引进和创新驱动发展。
发行价格:
28.00
{"stockData":{"symbol":"300255","market":"SZ","secType":"STK","nameCN":"常山药业","latestPrice":35.29,"timestamp":1781247813000,"preClose":34.91,"halted":0,"volume":14341833,"delay":0,"changeRate":0.0109,"floatShares":918000000,"shares":919000000,"eps":-0.3872,"marketStatus":"已收盘","change":0.38,"latestTime":"06-12 15:00:00","open":35.15,"high":36,"low":34.67,"amount":509000000,"amplitude":0.0381,"askPrice":35.3,"askSize":170,"bidPrice":35.29,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.3872,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":34.91,"symbolType":"stock","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":38.4,"lowLimit":31.42,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":919060878,"isCdr":false,"pbRate":26.51,"roa":"--","roe":"0.49%","epsLYR":-0.39,"committee":-0.556604,"marketValue":32434000000,"turnoverRate":0.0156,"status":0,"floatMarketCap":32383000000},"requestUrl":"/m/hq/s/300255","defaultTab":"news","newsList":[{"id":"2642238407","title":"6月11日常山药业跌6.88%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642238407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642238407?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:32","pubTimestamp":1781166769,"startTime":"0","endTime":"0","summary":"证券之星消息,6月11日常山药业跌6.88%创60日新低,收盘报34.91元,换手率2.2%,成交量20.23万手,成交额7.19亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100025677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","160219","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463726","title":"6月9日常山药业涨7.65%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642463726?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:51","pubTimestamp":1780995061,"startTime":"0","endTime":"0","summary":"证券之星消息,6月9日常山药业涨7.65%,收盘报39.8元,换手率3.38%,成交量30.97万手,成交额12.46亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900027277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641116546","title":"6月5日常山药业跌5.49%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116546?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:43","pubTimestamp":1780649003,"startTime":"0","endTime":"0","summary":"证券之星消息,6月5日常山药业跌5.49%,收盘报37.53元,换手率1.98%,成交量18.15万手,成交额6.99亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0070","160219","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640156432","title":"常山药业(300255)5月29日股东户数4.69万户,较上期减少0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640156432","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640156432?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:43","pubTimestamp":1780566209,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年5月29日公司股东户数为4.69万户,较5月20日减少307.0户,减幅为0.65%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至5月29日,化学制药行业平均股东户数为3.54万户。从股价来看,2026年5月20日至2026年5月29日,常山药业区间涨幅为2.08%,在此期间股东户数减少307.0户,减幅为0.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400031202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300255","BK0172","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640154138","title":"常山药业:2025年存货计提资产减值损失是由于当年末存货成本高于可变现净值","url":"https://stock-news.laohu8.com/highlight/detail?id=2640154138","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640154138?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:36","pubTimestamp":1780533371,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,25年公司存货减值较多,是何原因?今年是否会再做存货减值处理?常山药业回复:你好,2025年存货计提资产减值损失是由于当年末存货成本高于可变现净值。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400004793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0172","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640514138","title":"常山药业:股东协议转让事项的当事人是股东,而不是公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2640514138","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640514138?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:18","pubTimestamp":1780532290,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:好久没见到董秘回复提问了,请问1、截止5月底,公司股东人数多少?2、控股股东股份转让事宜,至今没有结果。是否有义务告知全体股东是什么原因。常山药业回复:你好,股东协议转让事项的当事人是股东,而不是公司。股东协议转让事项如有重大进展,公司将根据股东通知的内容予以公告。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400004415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0070","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639235636","title":"5月29日常山药业涨5.88%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639235636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639235636?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:54","pubTimestamp":1780044882,"startTime":"0","endTime":"0","summary":"证券之星消息,5月29日常山药业涨5.88%,收盘报41.25元,换手率2.79%,成交量25.59万手,成交额10.25亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300255","BK0172","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638666304","title":"股市必读:常山药业(300255)5月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638666304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638666304?lang=zh_cn&edition=full","pubTime":"2026-05-25 01:55","pubTimestamp":1779645311,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,常山药业报收于40.68元,上涨0.35%,换手率1.54%,成交量14.14万手,成交额5.73亿元。投资者: 请问一下刘董,截止2026年5月15日,常山药业股东户数是多少?董秘: 你好,公司不掌握截至5月15日的股东数据。截至2026年5月20日,公司的股东户数为47219户。当日关注点来自交易信息汇总:5月22日主力资金净流入1495.3万元,游资积极介入,散户资金呈净流出态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500000810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0172","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637394321","title":"常山药业:截至2026年5月20日,公司的股东户数为47219户","url":"https://stock-news.laohu8.com/highlight/detail?id=2637394321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637394321?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:06","pubTimestamp":1779437169,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问一下刘董,截止2026年5月15日,常山药业股东户数是多少?元素与大股东的过户能否有个时间轴?太久了,不然有引导散户买入的怀疑?常山药业回复:你好,公司不掌握截至5月15日的股东数据。截至2026年5月20日,公司的股东户数为47219户。以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200027906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637391478","title":"常山药业:推进艾本那肽上市审评工作是公司的重点工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2637391478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637391478?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:03","pubTimestamp":1779436987,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,距离阿贝那肽上市申请已经提交审批了两年又一个月,经常有股吧大V说批的越晚越好,公司为什么不珍惜上市窗口期,为什么批的越慢越好?常山药业回复:你好,推进艾本那肽上市审评工作是公司的重点工作,公司一直在努力推进,肯定希望能够尽早完成审评工作。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200027544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636106848","title":"常山药业(300255)披露2025年度股东会决议公告,5月20日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636106848","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636106848?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:21","pubTimestamp":1779268887,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,常山药业报收于40.41元,较前一交易日下跌1.44%,最新总市值为371.39亿元。该股当日开盘40.23元,最高40.82元,最低39.66元,成交额达5.02亿元,换手率为1.36%。公司于近日披露《2025年度股东会决议公告》。公告显示,河北常山生化药业股份有限公司于2026年5月19日召开2025年度股东会,会议由董事会召集,董事长高晓东主持,采用现场与网络投票结合方式举行。出席股东426名,代表有表决权股份297,063,467股,占公司有表决权股份总数的32.3225%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000031297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","300255","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636018739","title":"股市必读:常山药业(300255)股东户数4.77万户,较上期减少2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636018739","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636018739?lang=zh_cn&edition=full","pubTime":"2026-05-18 01:07","pubTimestamp":1779037631,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,常山药业报收于41.9元,下跌1.43%,换手率1.8%,成交量16.53万手,成交额6.91亿元。来自股本股东变化:截至5月8日股东户数环比下降2.45%,户均持股上升至1.93万股,显示筹码集中度提升。股本股东变化股东户数变动近日常山药业披露,截至2026年5月8日公司股东户数为4.77万户,较4月30日减少1200.0户,减幅为2.45%。户均持股数量由上期的1.88万股增加至1.93万股,户均持股市值为88.82万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800000487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300255","BK0172","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635355706","title":"常山药业:截至2026年5月8日,公司的股东户数为47692户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635355706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635355706?lang=zh_cn&edition=full","pubTime":"2026-05-15 15:09","pubTimestamp":1778828954,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)05月15日在投资者关系平台上答复投资者关心的问题。投资者提问:刘董,你好,请问截至止2026年5月10日公司的股东总数是多少?谢谢!常山药业回复:你好,截至2026年5月8日,公司的股东户数为47692户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500021707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","BK0239","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635270792","title":"5月14日常山药业跌6.84%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635270792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635270792?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:39","pubTimestamp":1778747942,"startTime":"0","endTime":"0","summary":"证券之星消息,5月14日常山药业跌6.84%,收盘报42.51元,换手率2.58%,成交量23.64万手,成交额10.24亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰目前规模为0.76亿元,最新净值1.0762,较上一交易日下跌0.03%,近一年上涨4.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400028792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","000300.SH","510880","512510","512880","159967","BK0239","399001","515890","000688.SH","510300","300255","000905.SH","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634003218","title":"常山药业因业绩预测结果不准确或不及时被深圳证券交易所采取监管措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2634003218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634003218?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:01","pubTimestamp":1778583661,"startTime":"0","endTime":"0","summary":"证券之星消息,5月11日常山药业公开信息显示,河北常山生化药业股份有限公司因业绩预测结果不准确或不及时被深圳证券交易所创业板公司管理部采取监管措施。2026年4月29日,你公司披露《2025年年度报告》,2025年度经审计净利润为-35789.56万元,经审计扣非后净利润为-35695.24万元。你公司业绩预告披露的业绩与实际业绩差异较大,且未能及时修正。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200034264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0172","BK0070","399001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633875384","title":"常山药业:截至2026年4月30日,公司的股东户数为48892户","url":"https://stock-news.laohu8.com/highlight/detail?id=2633875384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633875384?lang=zh_cn&edition=full","pubTime":"2026-05-08 15:01","pubTimestamp":1778223668,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至止2026年4月30日公司的股东总数是多少?谢谢常山药业回复:你好,截至2026年4月30日,公司的股东户数为48892户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800021188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0070","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633487304","title":"常山药业:公司未开展艾本那肽与其他同类药品的头对头临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2633487304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633487304?lang=zh_cn&edition=full","pubTime":"2026-05-08 15:01","pubTimestamp":1778223665,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请问阿贝那肽和目前已上市的glp-1在减重,降糖等方面有什么差异化优势?常山药业回复:你好,公司未开展艾本那肽与其他同类药品的头对头临床试验。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800021186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","300255","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633902592","title":"常山药业(300255.SZ):达肝素钠注射液获得白俄罗斯药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633902592","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633902592?lang=zh_cn&edition=full","pubTime":"2026-05-06 15:48","pubTimestamp":1778053689,"startTime":"0","endTime":"0","summary":"智通财经APP讯,常山药业(300255.SZ)发布公告,公司于近日收到通知,公司药品达肝素钠注射液获得白俄罗斯药品管理部门签发的药品注册证书。本次达肝素钠注射液获得白俄罗斯注册批文,对公司拓展海外市场带来一定积极影响。目前公司肝素制剂产品海外销售收入占公司营业总收入比例较低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300255","BK0070","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632767244","title":"每周股票复盘:常山药业(300255)2025年亏损3.58亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632767244","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632767244?lang=zh_cn&edition=full","pubTime":"2026-05-03 04:46","pubTimestamp":1777754771,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,常山药业报收于41.36元,较上周的39.59元上涨4.47%。本周,常山药业4月30日盘中最高价报43.8元。业绩披露要点:常山药业2025年归母净利润为-3.58亿元,同比下降43.46%。公司公告汇总:常山药业2025年年报显示,公司计划不派发现金红利,不送红股,不以公积金转增股本。股本股东变化股东户数变动截至2026年4月20日,常山药业股东户数为5.03万户,较4月10日减少2629户,减幅为4.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631578845","title":"常山药业(300255)2026年一季报简析:净利润同比增长55.21%,短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631578845","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631578845?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:41","pubTimestamp":1777502489,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期常山药业发布2026年一季报。截至本报告期末,公司营业总收入2.56亿元,同比下降1.0%,归母净利润587.1万元,同比上升55.21%。本报告期常山药业短期债务压力上升,流动比率达0.74。本次财报公布的各项数据指标表现一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781323789460,"stockEarnings":[{"period":"1week","weight":-0.0597},{"period":"1month","weight":-0.2266},{"period":"3month","weight":-0.1559},{"period":"6month","weight":-0.4827},{"period":"1year","weight":-0.3268},{"period":"ytd","weight":-0.4317}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河北常山生化药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44498人(较上一季度减少5.15%)","perCapita":"20621股","listingDate":"2011-08-19","address":"河北省石家庄市正定县中国(河北)自由贸易试验区正定片区高新技术产业开发区南区梦龙街71号","registeredCapital":"91906万元","survey":" 河北常山生化药业股份有限公司的主营业务是肝素系列产品的研发、生产和销售。公司的主要产品是普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司近几年分别被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等,建立了国家级博士后科研工作站,有效推动公司高级人才引进和创新驱动发展。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"常山药业,300255,常山药业股票,常山药业股票老虎,常山药业股票老虎国际,常山药业行情,常山药业股票行情,常山药业股价,常山药业股市,常山药业股票价格,常山药业股票交易,常山药业股票购买,常山药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}